全球医疗分析检测服务市场规模、份额、趋势和成长分析报告（2026-2034年）

预计医疗分析测试服务市场将从 2025 年的 9.3 亿美元成长到 2034 年的 23.7 亿美元，2026 年至 2034 年的复合年增长率为 10.97%。

医药分析检测服务市场的发展动力源于製药和生物製药公司对外包分析能力的日益依赖，以加速产品研发并确保合规性。这种需求涵盖小分子和生物製药的特性分析和稳定性测试，以及细胞和基因疗法复杂分析方法的开发。外包服务能够提供专业知识、可扩展的处理能力和法规方面的专长。面对日益复杂的产品和更严格的监管审查，这些优势至关重要。分析服务供应商被视为企业内部研发和品管职能的策略延伸。

成长要素包括药物研发量的增加、生物製药和先进治疗方法的激增（这些都需要专门的检测方法），以及监管机构对可靠分析表征的日益增长的要求。对高分辨率质谱、自动化和生物分析平台的技术投资正在实现更快、更高通量的检测。此外，提供整合资料管理、法规咨询和全球样品物流服务的商业实验室，正在为寻求加快产品上市速度的申办者打造极具吸引力的一站式解决方案。

前景依然强劲。在日益复杂的市场环境和持续的外包趋势的推动下，市场预计将保持两位数成长。投资于数位化平台、标准化方法和全球布局的供应商将获得大规模的合约。透过应对新型疗法（细胞、基因和RNA疗法）、即时分析以及缩短审批週期的监管资讯能力，分析测试服务将成为不断发展的药物研发生态系统中不可或缺的合作伙伴，从​​而实现策略差异化。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球医疗分析检测服务市场：按类型划分

• 市场分析、洞察与预测
• 原料检测服务
• 批量放行测试服务
• 实物资产评估服务
• 微生物检测
• 环境监测服务
• 空气检测
• 污水/污水处理厂检测

第五章：全球医疗分析检测服务市场：依最终用户划分

• 市场分析、洞察与预测
• 製药公司和生物製药公司
• 医疗设备製造商
• 受託研究机构

第六章 全球医疗分析检测服务市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck KGAA
  • Charles River Laboratories
  • WuXi PharmaTech
  • LabCorp
  • Eurofins Scientific
  • Pace Analytical
  • SGS

The Healthcare Analytical Testing Services Market size is expected to reach USD 2.37 Billion in 2034 from USD 0.93 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The healthcare analytical testing services market is buoyed by pharmaceutical and biopharma companies' growing reliance on outsourced analytical capabilities to accelerate development and ensure compliance. Demand spans small-molecule and biologic characterization, stability testing, and complex method development for cell and gene therapies. Outsourcing provides specialized expertise, scalable capacity, and regulatory know-how-critical as product complexity rises and regulatory scrutiny intensifies-making analytical service providers a strategic extension of in-house R&D and QC functions.

Growth drivers include increasing drug development volumes, the surge in biologics and advanced therapies that require specialized assays, and regulatory expectations for robust analytical characterization. Technology investments-high-resolution mass spectrometry, automation, and bioanalytical platforms-are enabling faster, higher-throughput testing. Additionally, commercial labs offering integrated data management, regulatory consulting, and global sample logistics create a one-stop proposition attractive to sponsors seeking faster time-to-market.

Future prospects are strong: the market will likely see sustained double-digit growth as complexity and outsourcing preference continue. Providers that invest in digital platforms, standardized methods, and global footprint will win larger contracts. Strategic differentiation will come from capabilities in novel modalities (cell, gene, RNA therapeutics), real-time analytics, and regulatory intelligence that shortens review cycles-positioning analytical testing services as indispensable partners in the evolving drug-development ecosystem.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Raw Material Testing Services
• Batch-release Testing Services
• Physical Characterization Services
• Microbial Testing
• Environmental Monitoring Services
• Air Testing
• Wastewater/ETP Testing

By End User

• Pharmaceutical and Biopharmaceutical Companies
• Medical Device Companies
• Contract Research Organizations

COMPANIES PROFILED

• Merck KGAA, Charles River Laboratories, WuXi PharmaTech, LabCorp, Eurofins Scientific, Pace Analytical, SGS
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Raw Material Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Batch-release Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Physical Characterization Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Microbial Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Environmental Monitoring Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Air Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Wastewater/ETP Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical and Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck KGAA
  • 8.2.2 Charles River Laboratories
  • 8.2.3 WuXi PharmaTech
  • 8.2.4 LabCorp
  • 8.2.5 Eurofins Scientific
  • 8.2.6 Pace Analytical
  • 8.2.7 SGS